ArticlePreventive medicine reports2026
Assessing the causal effect of tobacco retail density on cardiovascular and pulmonary disease hospitalizations in the United States.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: High tobacco retail density is linked to greater tobacco-related disease, but most evidence is cross-sectional limiting causal inference. Here, we use longitudinal data (2002-2016) from 327 counties in five U.S. states to estimate the causal effect of reducing tobacco retail density on hospitalizations for cardiovascular and pulmonary diseases. Methods: County-level data for Kentucky, Maryland, New Jersey, New York, and North Carolina were included. Annual rates of hospitalizations for acute myocardial infarction, asthma, chronic obstructive pulmonary disease (COPD), ischemic heart disease (IHD), and stroke were analyzed; annual tobacco retail density was dichotomized at ≥1.26 retailers per 1000 population. Marginal structural models with stabilized inverse probability weights were used to adjust for time-varying confounders. Results: High tobacco retail density was associated with increased hospitalization incidence rate ratios (IRR) for asthma (IRR = 1.43 [1.21, 1.69]), COPD (IRR = 1.13 [95%CI: 1.01, 1.25]), IHD (IRR = 1.09 [95%CI: 1.00, 1.18]), and stroke (IRR = 1.08 [95%CI: 1.01, 1.15]). Incidence rate differences indicated that had all counties been below the cut point, thousands of hospitalizations would have been prevented over the 15-year study period. Conclusion: These findings provide further evidence supporting retail-focused tobacco control policies as effective strategies to reduce the burden of tobacco-related disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.